BAJAJ BROKING
Dr Reddy’s Laboratories inaugurated a 70,000 sq ft biologics facility in Genome Valley, Hyderabad, through its subsidiary Aurigene, emphasising process and analytical development for antibodies and recombinant proteins. It aligns with Dr Reddy’s commitment to advancing biologics research and development.
Dr Reddy’s Laboratories revealed the inauguration of a new biologics facility spanning 70,000 sq ft in Genome Valley, Hyderabad, operated by its subsidiary, Aurigene Pharmaceutical Services Limited. The facility aims to address process and analytical development and small-scale manufacturing requirements for antibodies and other recombinant proteins.
Explore: Dr. Reddy's Laboratories
While the process and analytical development laboratories are already operational, the manufacturing capacity is slated for completion later in 2024, as per a regulatory filing by Dr Reddy’s Labs.
This addition complements the company’s existing infrastructure, concentrating on various recombinant proteins such as monoclonal antibodies (mAbs), bi- and multi-specifics, and immune-fusion molecules.
Aurigene's service spectrum now covers discovery to large-scale commercial manufacturing, facilitated by three nearby campuses. This alignment ensures seamless progression from conceptualization to commercialization, catering to diverse customer needs.
Aurigene CEO Akhil Ravi expressed confidence that the new facility's capabilities will enhance global customer service and support innovative medicine development.
Dr Roger Lias, Aurigene's global commercial head for biologics, emphasised the rarity of global CDMOs providing end-to-end services, highlighting Aurigene's strengthened capabilities and technical prowess.
The industry also witnessed Aurobindo Pharma's subsidiary, TheraNym Biologics Pvt Ltd, securing a contract manufacturing agreement with Merck Sharpe & Dohme Singapore Trading Pte Ltd for biological production. Additionally, researchers at IISc introduced a safer protein production method using MSG, replacing hazardous methanol.
This comprehensive expansion underscores Dr Reddy’s commitment to strengthening its biologics capabilities and serving the evolving needs of the pharmaceutical industry.
Additional Read: Dr. Reddy's Laboratories Ltd.
Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.
This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For All Disclaimers Click Here: https://bit.ly/3Tcsfuc
Share this article:
7th Pay Commission Leave Rules & Holidays in India
11 Dec, 2024 | 5 Min. read
Wipro Ltd
11 Dec, 2024 | 7 Min. read
Aditya Birla Group
11 Dec, 2024 | 10 Min. read
What is the Lock-in Period in IPO
11 Dec, 2024 | 6 Min. read
Textile Sector in India
11 Dec, 2024 | 11 Min. read
Step-by-Step Guide to Accessing Your Income Tax Assessment Order Online
11 Dec, 2024 | 3 Min. read
IPO vs FPO vs OFS: Key Differences in How Companies Raise Capital
11 Dec, 2024 | 8 Min. read
Gold Price in India - Gold Prices Edge Higher as Futures Hit $2,654.50
11 Dec, 2024 | 39 Min. read
Indian Overseas Bank Secures ₹1,359 Crore Income Tax Refund for AY 2015-16
11 Dec, 2024 | 2 Min. read
HG Infra Secures ₹899 Crore NH-227B Road Upgrade Project in UP
11 Dec, 2024 | 2 Min. read
NTPC Green Energy Secures 500 MW Solar Project with 250 MW ESS from SECI
11 Dec, 2024 | 2 Min. read
Awfis Space ₹583 Crore Block Deal Launches at ₹680 Floor Price
11 Dec, 2024 | 2 Min. read
RBI Launches ULI: Transforming Loan Access
August 27, 2024 | 4 Min. read
Textile Sector in India
September 20, 2024 | 5 Min. read
List of IPOs with DRHPs Filed
November 30, 2023 | 3 Min. read
Aditya Birla Group
September 28, 2023 | 10 Min. read
Bajaj Housing Finance Ltd IPO: Things Smart Investors Need to Know
September 05, 2024 | 4 Min. read
Budget Stock Ideas 2024-2025 | Stocks to Buy Today
July 24, 2024 | 4 Min. read
IPO Eligibility Criteria : Full Details
March 15, 2024 | 6 Min. read
What Is the Lock-In Period in IPOs?
October 18, 2023 | 6 Min. read
Godfrey Phillips Announces 2:1 Bonus Shares
September 16, 2024 | 7 Min. read
Jindal Group- A Comprehensive Analysis
September 27, 2024 | 7 Min. read
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading